Drug archive
Carboplatin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Carboplatin (KAR-boe-pla-tin) belongs to the group of medicines known as alkylating agents. It is used to treat cancer of the ovaries. It may also be used to treat other kinds of cancer, as determined by your doctor.
Carboplatin interferes with the growth of cancer cells, which eventually are destroyed. Since the growth of normal body cells may also be affected by carboplatin, other effects also will occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.
Before you begin treatment with carboplatin, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Carboplatin is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Paraplatin
In Canada -
- Paraplatin
- Paraplatin-AQ